Level Bio ABFRA:4MB +8.00%23 Operating Margin % is -1.32% as of Mar. 2026. GuruFocus rates FRA:4MB with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Level Bio AB ranks worse than 56.37% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Level Bio AB's Operating Income for the
three
months ended in Mar. 2026 was €-0.01 Mil. Level Bio AB's Revenue for the
three
months ended in Mar. 2026 was €0.84 Mil. Therefore, Level Bio AB's Operating Margin % for the quarter that ended in Mar. 2026 was -1.32%.
The historical rank and industry rank for Level Bio AB's Operating Margin % or its related term are showing as below:
FRA:4MB'
s Operating Margin % Range Over the Past 10 Years
Min: -34.22 Med: -4.79 Max: 13.03
Current: -8.08
FRA:4MB's Operating Margin % is ranked worse than 56.37% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195
vs FRA:4MB: -8.08
Level Bio AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Level Bio AB's Operating Income for the
three
months ended in Mar. 2026 was €-0.01 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.25 Mil.
Warning Sign:
Level Bio AB has never been profitable in the past 3 years. It lost money every year.
Level Bio AB (FRA:4MB) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Level Bio AB Operating Margin % Related Terms
Level Bio AB Operating Margin % Historical Data
* Premium members only.
The historical data trend for Level Bio AB's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4MB vs TMO, DHR, IDXX: Operating Margin % Comparison
For the Diagnostics & Research subindustry, Level Bio AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Level Bio AB Operating Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Level Bio AB's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Level Bio AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Level Bio AB (FRA:4MB) has a Operating Margin % of -1.32% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Level Bio AB and its competitors. According to the industry distribution chart, Level Bio AB ranks #115 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 56.4%.
Is Level Bio AB's Operating Margin % too high?
Level Bio AB's current Operating Margin % is -1.32%. Based on the distribution chart, Level Bio AB ranks #115 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #115 out of 204 companies for Operating Margin %. This places Level Bio AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Level Bio AB and its competitors. Level Bio AB's current Operating Margin % is -1.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (FRA:4MB) has a current Operating Margin % of -1.32%. The current Operating Margin % is -1.32%. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Level Bio AB (FRA:4MB), the current Operating Margin % is -1.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score
Get the complete analysis for FRA:4MB
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4MB has been successfully added to your 
